Researchers created the world’s smallest fully programmable autonomous robots. They measure about 0.2 by 0.3 by 0.05 millimeters, a size similar to many microorganisms. Each robot costs about one penny and can operate for months without external power.
The robots are light-powered and receive both energy and programming from pulses of light. Each device has a unique identifier so it can get different instructions. A batch described in Science Robotics carries temperature sensors that are quite accurate, and the robots report temperatures by wiggling, a motion like the waggle dance of honeybees.
The robots move without moving parts: an electrical field nudges ions in the liquid and pushes the robot. Most of the robot surface is solar panels to collect energy. Researchers say the devices could help medicine and manufacturing in the future.
Difficult words
- autonomous — Can work alone without external control.
- programmable — Can receive instructions and change its behavior.
- microorganism — A very small living thing seen with a microscope.microorganisms
- sensor — A device that measures temperature or other things.sensors
- identifier — A code or mark that tells which device.
- solar panel — A device that makes electricity from sunlight.solar panels
- ion — A charged atom or molecule in a liquid or gas.ions
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Would you like tiny robots to help in medicine? Why or why not?
- What could be a problem if robots operate without external power?
- Where would you use these small, cheap robots? Give one example.
Related articles
Algae-based synthetic gel supports mammary tissue growth
In 2020 a PhD student and her adviser at UC Santa Barbara developed an algae-based synthetic membrane to support mammary epithelial cells. Their tunable gel, reported in Science Advances, can direct cell growth by changing mechanical and biochemical cues.
Lack of African research weakens policy and trade
The African Academy of Sciences warns that too little scientific evidence produced in Africa makes policy and trade harder. The AAS is building networks, starting a science diplomacy programme and trying to restore trust after funding problems.
Affordable twice-yearly HIV injection lenacapavir to reach 120 countries
Lenacapavir, a twice-yearly HIV prevention injection, will be licensed for 120 low- and middle-income countries at US$40 a year. Rollout is expected from 2027 with funding support, but some countries and price transparency remain concerns.